Description
Sparsentan 400mg Tablets
Information Sparsentan is an orally administered dual endothelin receptor and angiotensin II receptorantagonist developed for proteinuric kidney diseases.
Mechanism of Action Sparsentan reduces intraglomerular pressure and proteinuria.- Blocks endothelin type A receptors- Antagonizes angiotensin II type 1 receptors- Reduces glomerular inflammation and fibrosis
Uses / Indications Used in nephrology practice.- IgA nephropathy- Focal segmental glomerulosclerosis
Side Effects Generally related to blood pressure reduction.- Hypotension- Peripheral edema- Dizziness
Warnings & Precautions Monitoring is required.- Monitor blood pressure regularly- Assess renal function and potassium levels
Conclusion Sparsentan offers dual pathway blockade for effective reduction of proteinuria in kidneydisease.This information is intended for educational purposes only and should not replace clinicaljudgment. Treatment decisions must be made by qualified healthcare professionals.
Reviews
There are no reviews yet.